Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H17ClFN3O2S |
| Molecular Weight | 441.906 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C1=CC=C(C=N1)C2=C(OC(=N2)C3=CC=C(F)C=C3)SC4=CC=C(Cl)C=N4
InChI
InChIKey=DBZMCSVIITXLCC-UHFFFAOYSA-N
InChI=1S/C22H17ClFN3O2S/c1-22(2,28)17-9-5-14(11-25-17)19-21(30-18-10-6-15(23)12-26-18)29-20(27-19)13-3-7-16(24)8-4-13/h3-12,28H,1-2H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
77GX6MU9ZL
Created by
admin on Tue Apr 01 16:55:41 GMT 2025 , Edited by admin on Tue Apr 01 16:55:41 GMT 2025
|
PRIMARY | |||
|
1207745-58-1
Created by
admin on Tue Apr 01 16:55:41 GMT 2025 , Edited by admin on Tue Apr 01 16:55:41 GMT 2025
|
PRIMARY | |||
|
MK-4409
Created by
admin on Tue Apr 01 16:55:41 GMT 2025 , Edited by admin on Tue Apr 01 16:55:41 GMT 2025
|
PRIMARY | MK-4409 is a drug which acts as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), with an IC50 of 11 nM, and both analgesic and antiinflammatory effects in animal studies. It was developed for the treatment of neuropathic pain and has progressed as far as early stage human clinical trials. | ||
|
DTXSID101045923
Created by
admin on Tue Apr 01 16:55:41 GMT 2025 , Edited by admin on Tue Apr 01 16:55:41 GMT 2025
|
PRIMARY | |||
|
53341130
Created by
admin on Tue Apr 01 16:55:41 GMT 2025 , Edited by admin on Tue Apr 01 16:55:41 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
